Mar 19 |
Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
Mar 19 |
Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
|
Mar 18 |
Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?
|
Mar 11 |
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
|
Mar 11 |
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
|
Mar 10 |
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
|
Mar 9 |
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
|
Mar 9 |
Peabody Energy, Citi Trends, and More Stocks See Action From Activist Investors
|
Mar 4 |
Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
|
Mar 4 |
Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
|